# PALBOCICLIB
> **ANDA213086** · Abbreviated New Drug Application (Generic) · Sponsor: EUGIA PHARMA SPECLTS · Approved 2022-07-07
## Drug
- **FDA Application Number:** ANDA213086
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** PALBOCICLIB
- **Generic name:** Palbociclib
- **Active ingredients:** PALBOCICLIB
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** EUGIA PHARMA SPECLTS
- **First approval:** 2022-07-07
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213086)
---
*AI Analytics · CC0 1.0*